ArticleIn silico pharmacology2025

Targeting Acute Myeloid Leukemia with 1,2,4-triazolo[4,3-b]pyridazine derivatives: a molecular docking, dynamics, and ADMET approach.

Vincent A Obakachi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.